Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released May 5, 2016, after the close
10-Q filed May 5, 2016, 35 days after period end · 0001299130-16-000198
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Revenue | $19.13M | $17.65M | $11.64M | $5.58M |
| Net Income | -$19.35M | -$20.17M | -$18.89M | -$21.10M |
| EPS Diluted | -$0.23 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.27 |
| -$0.28 |
| -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
